G.ST ANTIVIRALS
G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
G.ST ANTIVIRALS
Social Links:
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.gst-antivirals.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Amazon Organization Schema Google Apps For Business Google Google Cloud
Current Employees Featured
Founder
Investors List
IST cube
IST cube investment in Series A - G.ST Antivirals
Official Site Inspections
http://www.gst-antivirals.com
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "G.ST Antivirals"
G.ST Antivirals
Apr 9, 2024 G.ST Antivirals is currently working on tackling two indications of high medical …See details»
G.ST Antivirals - Crunchbase Company Profile & Funding
G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals against infections of the respiratory tract.See details»
G.ST Antivirals 2025 Company Profile: Valuation, …
May 8, 2020 Information on valuation, funding, cap tables, investors, and executives for G.ST Antivirals. Use the PitchBook Platform to explore the full …See details»
G.ST Antivirals - Vienna BioCenter
G.ST Antivirals is dedicated to the development of therapies against different viruses applying an entirely novel approach of antiviral therapy. The MedUni Vienna spin-off utilizes the viral dependency on the host cell metabolism and …See details»
G.ST Antivirals - LinkedIn
About us G.ST Antivirals applies an innovative host cell-based strategy to develop broad …See details»
G.ST Antivirals - Executive Bio, Top Executies, and Transitions ...
View the organization profile of G.ST Antivirals,Guido Gualdoni holds both an MD and a PhD …See details»
G.ST Antivirals GmbH Company Profile | Wien, Wien, Austria ...
Find company research, competitor information, contact details & financial data for G.ST …See details»
G.ST Antivirals Company Profile - Office Locations, Competitors
G.ST Antivirals has 1 employees across 2 locations. See insights on G.ST Antivirals including …See details»
Life Sciences Directory: G.ST Antivirals GmbH
Organization type RDM biotech/pharma Region Lower Austria Cluster ecoplus Focus human …See details»
xista Ventures: Detail
G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals …See details»
Team - G.ST Antivirals
Anna-Dorothea Gorki is an expert in respiratory tract infections trained at the Research Center of Molecular Medicine (CeMM, Austrian Academy of Sciences) and the Medical University of …See details»
G.ST Antivirals - Products, Competitors, Financials, Employees ...
About G.ST Antivirals G.ST Antivirals is a clinical-stage biotech company focused on …See details»
G.ST Antivirals reports start of Phase II trial and announces ...
Vienna, Austria, April 9, 2024 – G.ST Antivirals, a clinical-stage biotechnology company …See details»
G.ST Antivirals - Profiles & Contacts - Crunchbase
G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals …See details»
G.ST Antivirals - EU-Startups
Sep 23, 2021 G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals …See details»
Careers - G.ST Antivirals
G.ST Antivirals is a rapidly growing Start-up at the heart of Vienna’s biotech industry, the …See details»
G.ST Antivirals reports positive Phase I trial results
Jan 25, 2024 G.ST Antivirals reported positive results from Phase I clinical trials on its lead …See details»
News - G.ST Antivirals
May 10, 2022 G.ST Antivirals to expand its innovative host cell-based treatment approach to …See details»
G.ST Antivirals reports positive Phase I trial results for 2-Deoxy-D ...
Vienna, Austria, 25 January 2024 – G.ST Antivirals, a clinical-stage biotechnology company …See details»
Team - G.ST Antivirals
Guido Gualdoni hat sowohl das Medizinstudium als auch ein PhD-Studium in Immunologie an …See details»